Abstract
Kallikrein-related peptidase 6 (KLK6) is a secreted serine protease hypothesized to promote inflammation via cleavage of protease-activated receptor 1 (PAR1) and PAR2. KLK6 levels are elevated in multiple inflammatory and autoimmune conditions, but no definitive role in pathogenesis has been established. Here, we show that skin-targeted overexpression of KLK6 causes generalized, severe psoriasiform dermatitis with spontaneous development of debilitating psoriatic arthritis-like joint disease. The psoriatic skin and joint phenotypes are reversed by normalization of skin KLK6 levels and attenuated following genetic elimination of PAR1 but not PAR2. Conservation of this regulatory pathway was confirmed in human psoriasis using vorapaxar, an FDA-approved PAR1 antagonist, on explanted lesional skin from patients with psoriasis. Beyond defining a critical role for KLK6/PAR1 signaling in promoting psoriasis, our results demonstrate that KLK6/PAR1-mediated inflammation in the skin alone is sufficient to drive inflammatory joint disease. Further, we identify PAR1 as a promising cytokine-independent target in therapy of psoriasis and psoriatic arthritis.
References
Nov 9, 2000·The Journal of Investigative Dermatology·I DiamondA Glick
Sep 16, 2005·Nature·Rainer ZenzErwin F Wagner
Feb 18, 2011·The Journal of Rheumatology·Lihi EderDafna D Gladman
Jun 9, 2012·The Journal of Allergy and Clinical Immunology·James G KruegerRobert W Hoffman
Oct 26, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Azza EissaVinod Chandran
May 3, 2014·The Journal of Allergy and Clinical Immunology·Saakshi KhattriEmma Guttman-Yassky
Jul 11, 2014·Science Translational Medicine·Maria QuarantaKilian Eyerich
Aug 22, 2014·PloS One·Angelique StalmachDuncan Porter
Sep 1, 2015·Neurobiology of Disease·Maja RadulovicIsobel A Scarisbrick
May 5, 2016·Neurobiology of Disease·Maja RadulovicIsobel A Scarisbrick
Jun 14, 2016·The Journal of Clinical Investigation·Mårten C G WingeM Peter Marinkovich
Feb 19, 2017·Journal of the American Academy of Dermatology·Junko TakeshitaJoel M Gelfand
Mar 21, 2017·Journal of the American Academy of Dermatology·Parul KathuriaJonathan I Silverberg
Feb 14, 2018·Arthritis & Rheumatology·Lu YangSergei B Koralov
Aug 16, 2018·Clinical Reviews in Allergy & Immunology·Andrew Blauvelt, Andrea Chiricozzi
Jan 15, 2019·The Journal of Investigative Dermatology·Lam C TsoiStephan Weidinger
Citations
Apr 2, 2020·Nature Reviews. Rheumatology·Joanna Clarke
Jun 21, 2020·The Journal of Allergy and Clinical Immunology·Michael P SchönLuise Erpenbeck
Jun 14, 2020·The Journal of Investigative Dermatology·Piotr Konieczny, Shruti Naik
Feb 6, 2021·Experimental Dermatology·Georgia SotiropoulouGeorgios Pampalakis
Oct 16, 2020·JCI Insight·Yanyun JiangJohann E Gudjonsson
Jul 26, 2021·The Journal of Investigative Dermatology·Di YanWilson Liao
Aug 9, 2021·The Journal of Investigative Dermatology·Mehrnaz Gharaee-KermaniJ Michelle Kahlenberg
Aug 28, 2021·Cancers·Juliana B CandidoDaniela Loessner